CVS Health Corporation announced a strong third-quarter performance with revenues of $81.2 billion and a raised adjusted EPS guidance range of $8.55 to $8.65, reflecting robust market confidence. The company also declared a quarterly dividend of $0.55 per share, maintaining a 2.25% yield, supported by bullish sentiment from 67 hedge funds. In contrast, Meta Platforms, Inc. struggled with a 16% decline during the same period, underscoring CVS's favorable position in a volatile market.
“Meta Platforms, Inc. · was part of · hedge fund portfolios · 177”
“CVS Health Corporation · is an · American provider of health services · in the United States”
“CVS Health Corporation · owns · shares of CVS Health Corporation · 3.8 million shares”
“CVS Health Corporation · has · stake value · $365,686,000”
“Meta Platforms, Inc. · was down · during the quarter · 16%”
“CVS Health Corporation · reported · Q3 non-GAAP EPS · $2.09”
“CVS Health Corporation · reported · Q3 revenue · $81.2 billion”
“CVS Health Corporation · raised · adjusted EPS guidance range · $8.55-$8.65”
“67 hedge funds · were bullish on · CVS Health Corporation · at the end of Q3 2022”
“CVS Health Corporation · declared a quarterly dividend of · $0.55 per share · on September 22”
“CVS Health Corporation · has a dividend yield of · 2.25% · as of November 16”
“Abbott Laboratories · is a Dividend King · has raised its dividends consistently for 50 years”
